Showing results (281-290 of 308) with videos related to

Sort By:
Pageof 31
American Journal of Clinical Dermatology|January 22, 2021
Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or AsthmaAshish Bansal, Eric L Simpson, Amy S Paller, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2026
IL-13 signaling in cDC2 is required for systemic anaphylactic responsesYasuyo Harada, Takanori Sasaki, Kazushige Obata-Ninomiya, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
TSLP production by epithelial cells exposed to immunodeficiency virus triggers DC-mediated mucosal infection of CD4+ T cellsDanielle Fontenot, Hong He, Shino Hanabuchi, et al.
The Journal of Biological Chemistry|November 30, 2016
Versican Deficiency Significantly Reduces Lung Inflammatory Response Induced by Polyinosine-Polycytidylic Acid StimulationInkyung Kang, Ingrid A Harten, Mary Y Chang, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Transcriptomic Profiling of Bronchial Epithelium Reveals Dysregulated Interferon and Inflammatory Responses to Rhinovirus in Exacerbation-Prone Pediatric AsthmaNaresh Doni Jayavelu, Basilin Benson, Patricia C Dela Cruz, et al.
Biorxiv : the Preprint Server for Biology|December 22, 2025
IL-13 Modulates Antiviral Effector and Proinflammatory Pathways in Rhinovirus-Infected Pediatric Bronchial EpitheliumPatricia C Dela Cruz, Basilin Benson, Naresh Doni Jayavelu, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 7, 2022
Extrapolating Evidence-Based Medicine of AIT Into Clinical Practice in the United StatesMoisés A Calderon, Thomas B Casale, Harold S Nelson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 16, 2021
Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate to Severe Atopic DermatitisMark Boguniewicz, Lisa A Beck, Lawrence Sher, et al.
The Journal of Allergy and Clinical Immunology|October 12, 2022
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trialJonathan Corren, David Larson, Matthew C Altman, et al.
Pageof 31